Arrowhead Pharmaceuticals Inc (ARWR) Annual Balance Sheets

Annual · GAAP · USD millions
Access ARWR quarterly Balance Sheets →
Changes in quarterly balance sheet trends offer perspective on how Arrowhead Pharmaceuticals Inc balances growth, leverage, and shareholder equity.
Annual Report, GAAP in USD millions
ITEM
(Sep 30 2025)
(Sep 30 2024) (Sep 30 2023) (Sep 30 2022) (Sep 30 2021)
Assets
Cash & cash equivalent0.00
Short-term Investments, Total692.82
Cash & Short-term Investments692.00
Accounts receivable6.82
Other Current Assets240.06
Prepaid Expense, Current AS10.93
Total Current Assets950.64
Equipment/Property/Plant Net382.52
Intangible Assets6.86
Long-term investments0.00
Other Assets, Noncurrent4.00
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents226.55
Operating Lease Right Of Use Asset43.89
Total Assets1,385.30
Liabilities
Accounts Payable, Current AC17.67
Accrued Liabilities, Current117.31
Line of Credit, Current LO40.00
Other Liabilities, Current20.50
Total Current Liabilities195.49
Long-term debt214.88
Total Long-term Debt214.88
Operating Lease Liability Current7.29
Contract With Customer Liability Noncurrent-
Operating Lease Liability Noncurrent104.11
Total Liabilities410.37
Stockholders' Equity
Common Stock Value0.23
Additional Paid In Capital Common Stock2,139.73
Retained Earnings / Accumulated Deficit-1,627.15
Other Equity-46.75
Common Stockholder's Equity466.05
Non-controlling interests & other37.36
Total Stockholder's Equity503.42
Liabilities & Stockholder's Equity1,385.30
4 historic quarters locked

Sign in to unlock the full Arrowhead Pharmaceuticals Inc balance sheet history.

About Arrowhead Pharmaceuticals Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-K (Period: 20250930)
  • Filed with the SEC: November 25, 2025
  • Source: arwr-20250930.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0000879407-25-000029

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API License